Evidence map›Paper›PMID 23147219›Full record

ArticleMolecular bioSystems2013

A multi-omic systems approach to elucidating Yersinia virulence mechanisms.

Charles Ansong, Alexandra C Schrimpe-Rutledge, Hugh D Mitchell, Sadhana Chauhan, Marcus B Jones, Young-Mo Kim, Kathleen McAteer, Brooke L Deatherage Kaiser, Jennifer L Dubois, Heather M Brewer and 7 more

Abstract read
In one paragraph

Article in Molecular bioSystems, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The MPLEx Protocol for Multi-omic Analyses of Soil Samples.Journal of visualized experiments : JoVE · 2018
    Article
  6. Article
  7. Article
  8. Review
  9. Environmental Regulation of Yersinia Pathophysiology.Frontiers in cellular and infection microbiology · 2016
    Review
  10. A novel targeted/untargeted GC-Orbitrap metabolomics methodology applied toMetabolomics : Official journal of the Metabolomic Society · 2016
    Article
  11. Article
  12. Article
  13. Article
  14. Coregulation of host-adapted metabolism and virulence by pathogenic yersiniae.Frontiers in cellular and infection microbiology · 2014
    Review
  15. Article
  16. Review
  17. Omics strategies for revealing Yersinia pestis virulence.Frontiers in cellular and infection microbiology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Charles AnsongBiological Sciences Division, Pacific Northwest National Laboratory, P. O. Box 999, Richland, WA 99352, USA.
Alexandra C Schrimpe-Rutledge
Hugh D Mitchell
Sadhana Chauhan
Marcus B Jones
Young-Mo Kim
Kathleen McAteer
Brooke L Deatherage Kaiser
Jennifer L Dubois
Heather M Brewer
Bryan C Frank
Jason E McDermott
Thomas O Metz
Scott N Peterson
Richard D Smith
Vladimir L Motin
Joshua N Adkins
Pacific Northwest National Laboratory · USJ. Craig Venter Institute · USThe University of Texas Medical Branch at Galveston · USSRI International · USWashington State University Tri-Cities · US

Funding

WORKSHOP AND TRAINING ACTIVITIESP41RR018522 · NCRR · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2003 to 2011
$25.1M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
SURFACE CHEMISTRY OF MYCOBACTERIAR01AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1989 to 1989
–
SURFACE CHEMISTRY OF MYCOBACTERIAR22AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1985 to 1989
–
Intramural NIH HHSNCRR NIH HHS 5P41RR018522-10NCRR NIH HHS P41 RR018522NIAID NIH HHS Y01 AI008401NIAID NIH HHS Y1-AI-8401NIGMS NIH HHS 8 P41 GM103493-10NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

The underlying mechanisms that lead to dramatic differences between closely related pathogens are not always readily apparent. For example, the genomes of Yersinia pestis (YP) the causative agent of plague with a high mortality rate and Yersinia pseudotuberculosis (YPT) an enteric pathogen with a modest mortality rate are highly similar with some species specific differences; however the molecular causes of their distinct clinical outcomes remain poorly understood. In this study, a temporal multi-omic analysis of YP and YPT at physiologically relevant temperatures was performed to gain insights into how an acute and highly lethal bacterial pathogen, YP, differs from its less virulent progenitor, YPT. This analysis revealed higher gene and protein expression levels of conserved major virulence factors in YP relative to YPT, including the Yop virulon and the pH6 antigen. This suggests that adaptation in the regulatory architecture, in addition to the presence of unique genetic material, may contribute to the increased pathogenecity of YP relative to YPT. Additionally, global transcriptome and proteome responses of YP and YPT revealed conserved post-transcriptional control of metabolism and the translational machinery including the modulation of glutamate levels in Yersiniae. Finally, the omics data was coupled with a computational network analysis, allowing an efficient prediction of novel Yersinia virulence factors based on gene and protein expression patterns.

Indexed as

AnimalsBody TemperatureCluster AnalysisGene Expression ProfilingGlutamic AcidHost-Pathogen InteractionsMammalsModels, BiologicalProteomicsSiphonapteraTranscriptomeVirulenceYersiniaGlutamic Acid

Identifiers

PMID23147219
PMCPMC3518462
OpenAlexW2014426403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.